FDA permits experimental use of Iplex on ALS patients

03/11/2009 | Reuters

The FDA said it is allowing selected patients with Lou Gehrig's disease to use Iplex, Insmed's treatment for growth-hormone deficiency, as the company awaits the conclusion of a patent-infringement case that put sales on hold. Insmed plans to use part of its "very limited" supply of Iplex to conduct safety trials.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC